Enanta Pharmaceuticals (ENTA) Cash from Operations (2012 - 2026)
Enanta Pharmaceuticals posted quarterly Cash from Operations of 7156000.0 for Q1 2026, up 46.95% year-on-year from 4869834.91 in Q1 2025, and up 38.83% on a QoQ basis from 11699000.0 in Q4 2025.
Enanta Pharmaceuticals (ENTA) has 15 years of Cash from Operations data on file, last reported at 7156000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations rose 46.95% year-over-year to 7156000.0; the trailing twelve-month figure through Mar 2026 stood at 7838000.0 (up 85.87% YoY), and the FY2025 full-year result was 19272000.0, up 75.53% from the prior year.
- Cash from Operations for Q1 2026 stood at 7156000.0, up from 11699000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 17506000.0 in Q2 2025 and bottomed at 35641000.0 in Q4 2022.
- The 5-year median for Cash from Operations is 15534000.0 (2022), against an average of 17150352.94.
- The widest annual swing landed in 2022, when Cash from Operations tumbled 476.0%; it then surged 218.48% in 2025.
- A 5-year view of Cash from Operations shows it stood at 35641000.0 in 2022, then gained by 29.89% to 24988000.0 in 2023, then surged by 32.76% to 16801000.0 in 2024, then jumped by 30.37% to 11699000.0 in 2025, then soared by 38.83% to 7156000.0 in 2026.
- The last three Cash from Operations figures came in at 7156000.0 (Q1 2026), 11699000.0 (Q4 2025), and 6489000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | -7.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.16 Mn |
| Mar 31, 2026 | -7.16 Mn |
| Dec 31, 2025 | -11.70 Mn |
| Dec 31, 2025 | -11.70 Mn |
| Sep 30, 2025 | -6.49 Mn |
| Sep 30, 2025 | -6.49 Mn |
| Jun 30, 2025 | 17.51 Mn |
| Jun 30, 2025 | 17.51 Mn |
| Mar 31, 2025 | -13.49 Mn |
| Mar 31, 2025 | -13.49 Mn |
| Dec 31, 2024 | -16.80 Mn |
| Dec 31, 2024 | -16.80 Mn |
| Sep 30, 2024 | -10.40 Mn |
| Sep 30, 2024 | -10.40 Mn |
| Jun 30, 2024 | -14.78 Mn |
| Jun 30, 2024 | -14.78 Mn |
| Mar 31, 2024 | -28.60 Mn |
| Mar 31, 2024 | -28.60 Mn |
| Dec 31, 2023 | -24.99 Mn |
| Dec 31, 2023 | -24.99 Mn |
| Sep 30, 2023 | -21.60 Mn |
| Sep 30, 2023 | -21.60 Mn |
| Jun 30, 2023 | -32.13 Mn |
| Jun 30, 2023 | -32.13 Mn |
| Mar 31, 2023 | -13.78 Mn |
| Mar 31, 2023 | -13.78 Mn |
| Dec 31, 2022 | -35.64 Mn |
| Dec 31, 2022 | -35.64 Mn |
| Sep 30, 2022 | -15.53 Mn |
| Sep 30, 2022 | -15.53 Mn |
| Jun 30, 2022 | -29.60 Mn |
| Jun 30, 2022 | -29.60 Mn |
| Mar 31, 2022 | -26.38 Mn |
| Mar 31, 2022 | -26.38 Mn |
| Dec 31, 2021 | -13.27 Mn |
| Dec 31, 2021 | -13.27 Mn |
| Sep 30, 2021 | -21.02 Mn |
| Sep 30, 2021 | -21.02 Mn |
| Jun 30, 2021 | -29.51 Mn |
| Jun 30, 2021 | -29.51 Mn |
| Mar 31, 2021 | -4.58 Mn |
| Mar 31, 2021 | -4.58 Mn |
| Dec 31, 2020 | -14.89 Mn |
| Dec 31, 2020 | -14.89 Mn |
| Sep 30, 2020 | -15.46 Mn |
| Sep 30, 2020 | -15.46 Mn |
| Jun 30, 2020 | -4.49 Mn |
| Jun 30, 2020 | -4.49 Mn |
| Mar 31, 2020 | 14.67 Mn |
| Mar 31, 2020 | 14.67 Mn |
| Dec 31, 2019 | 12.36 Mn |
| Dec 31, 2019 | 12.36 Mn |
| Sep 30, 2019 | 8.55 Mn |
| Sep 30, 2019 | 8.55 Mn |
| Jun 30, 2019 | 2.53 Mn |
| Jun 30, 2019 | 2.53 Mn |
| Mar 31, 2019 | 30.09 Mn |
| Mar 31, 2019 | 30.09 Mn |
| Dec 31, 2018 | 30.25 Mn |
| Dec 31, 2018 | 30.25 Mn |
| Sep 30, 2018 | 28.34 Mn |
| Sep 30, 2018 | 28.34 Mn |
| Jun 30, 2018 | 4.05 Mn |
| Jun 30, 2018 | 4.05 Mn |
| Mar 31, 2018 | -7.58 Mn |
| Mar 31, 2018 | -7.58 Mn |
| Dec 31, 2017 | 4.41 Mn |
| Dec 31, 2017 | 4.41 Mn |
| Sep 30, 2017 | 57.31 Mn |
| Sep 30, 2017 | 57.31 Mn |
| Jun 30, 2017 | -4.80 Mn |
| Jun 30, 2017 | -4.80 Mn |
| Mar 31, 2017 | -3.00 Mn |
| Mar 31, 2017 | -3.00 Mn |
| Dec 31, 2016 | 3.15 Mn |
| Dec 31, 2016 | 3.15 Mn |
| Sep 30, 2016 | -2.13 Mn |
| Sep 30, 2016 | -2.13 Mn |
| Jun 30, 2016 | -2.11 Mn |
| Jun 30, 2016 | -2.11 Mn |
| Mar 31, 2016 | 10.05 Mn |
| Mar 31, 2016 | 10.05 Mn |
| Dec 31, 2015 | 29.99 Mn |
| Dec 31, 2015 | 29.99 Mn |
| Sep 30, 2015 | -2.38 Mn |
| Sep 30, 2015 | -2.38 Mn |
| Jun 30, 2015 | -14.20 Mn |
| Jun 30, 2015 | -14.20 Mn |
| Mar 31, 2015 | 98.86 Mn |
| Mar 31, 2015 | 98.86 Mn |
| Dec 31, 2014 | -5.61 Mn |
| Dec 31, 2014 | -5.61 Mn |
| Sep 30, 2014 | -4.93 Mn |
| Sep 30, 2014 | -4.93 Mn |
| Jun 30, 2014 | 35.11 Mn |
| Jun 30, 2014 | 35.11 Mn |
| Mar 31, 2014 | -4.13 Mn |
| Mar 31, 2014 | -4.13 Mn |
| Dec 31, 2013 | -5.87 Mn |
| Dec 31, 2013 | -5.87 Mn |
| Sep 30, 2013 | -2.50 Mn |
| Sep 30, 2013 | -2.50 Mn |
| Jun 30, 2013 | -5.92 Mn |
| Jun 30, 2013 | -5.92 Mn |
| Mar 31, 2013 | 10.03 Mn |
| Mar 31, 2013 | 10.03 Mn |
| Dec 31, 2012 | 9.05 Mn |
| Dec 31, 2012 | 9.05 Mn |
| Sep 30, 2012 | -1.70 Mn |
| Sep 30, 2012 | -1.70 Mn |
| Jun 30, 2012 | -3.83 Mn |
| Jun 30, 2012 | -3.83 Mn |